{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T10:32:06Z","timestamp":1791196326535,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychoneuroendocrinology"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1016\/j.psyneuen.2004.11.003","type":"journal-article","created":{"date-parts":[[2005,1,25]],"date-time":"2005-01-25T23:16:30Z","timestamp":1106694990000},"page":"431-437","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Male patients with paranoid schizophrenia have greater ACTH and cortisol secretion in response to metoclopramide-induced AVP release"],"prefix":"10.1016","volume":"30","author":[{"given":"Patricia","family":"Walsh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leona","family":"Spelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neda","family":"Sharifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jogin H.","family":"Thakore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psyneuen.2004.11.003_bib1","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0924-9338(03)00075-0","article-title":"Recent evidence for dopamine abnormalities in schizophrenia","volume":"17","author":"Abi-Dargham","year":"2002","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.psyneuen.2004.11.003_bib2","year":"1994"},{"key":"10.1016\/j.psyneuen.2004.11.003_bib3","unstructured":"Andreasen, N.C., 1983. The Scale for the Assessment of Negative Symptoms (SANS). Iowa City, The University of Iowa."},{"key":"10.1016\/j.psyneuen.2004.11.003_bib4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1126\/science.6143403","article-title":"Stress hormones: their interaction and regulation","volume":"224","author":"Axelrod","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.psyneuen.2004.11.003_bib5","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0028-3908(02)00149-1","article-title":"Chlorpromazine inhibits the glucocorticoid receptor-mediated gene transcription in a calcium-dependent manner","volume":"43","author":"Basta-Kaim","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.psyneuen.2004.11.003_bib6","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0306-4530(85)90056-3","article-title":"Vasopressin\u2013oxytocin in cerebrospinal fluid of schizophrenic patients and of normal controls","volume":"10","author":"Beckmann","year":"1985","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2004.11.003_bib7","first-page":"29","article-title":"Effect of dopamine, dopamine D-1 and D-2 receptor modulation on ACTH and cortisol levels in normal men and women","volume":"122","author":"Boesgaard","year":"1990","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1016\/j.psyneuen.2004.11.003_bib8","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/0024-3205(92)90563-5","article-title":"The effects of metabolic stress on plasma progesterone in healthy volunteers and schizophrenic patients","volume":"51","author":"Breier","year":"1992","journal-title":"Life Sci."},{"key":"10.1016\/j.psyneuen.2004.11.003_bib9","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1159\/000124925","article-title":"Neuropharmacological characterization of of serotonergic stimulation of vasopressin secretion in concious rats","volume":"47","author":"Brownfield","year":"1988","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.psyneuen.2004.11.003_bib10","first-page":"847","article-title":"Chronic psychosocial stress enhances vasopressin, but not corticotropin-releasing factor secretion, in the external zone of the median eminence of male rats: relationship to subordinate status","volume":"131","author":"de Goeji","year":"1991","journal-title":"Endocrinology"},{"key":"10.1016\/j.psyneuen.2004.11.003_bib11","first-page":"E394","article-title":"Chronic stress enhances vasopressin, but not coorticotropin-releasing factor secretion during hypoglycaemia","volume":"263","author":"de Goeji","year":"1992","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.psyneuen.2004.11.003_bib12","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1176\/ajp.155.7.979","article-title":"Effect of acute metabolic stress on pituitary\u2013adrenal axis activation in patients with schizophrenia","volume":"155","author":"Elman","year":"1998","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2004.11.003_bib13","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1177\/02698811030173014","article-title":"Effects of acute metabolic stress on the peripheral vasopressinergic system in schizophrenia","volume":"17","author":"Elman","year":"2003","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.psyneuen.2004.11.003_bib15","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/0006-3223(96)84253-3","article-title":"Haloperidol attenuates CRF release in the rat: A micro-dialysis study","volume":"39","author":"Forman","year":"1996","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2004.11.003_bib14","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0920-9964(94)90083-3","article-title":"Cerebrospinal fluid corticotropin-releasing factor increases following haloperidol withdrawal in chronic schizophrenia","volume":"12","author":"Forman","year":"1994","journal-title":"Schizophrenia Res."},{"key":"10.1016\/j.psyneuen.2004.11.003_bib16","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1600-0447.1991.tb05539.x","article-title":"Reduced concentrations of galanin, arginine vasopressin, neuropeptide Y and peptide YY in the temporal cortex but not in the hypothalamus of brains from schizophrenics","volume":"83","author":"Fredericksen","year":"1991","journal-title":"Acta Psychiatrica Scand."},{"key":"10.1016\/j.psyneuen.2004.11.003_bib17","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/BF00178514","article-title":"Diurnal rhythm of plasma beta endorphin, cortisol and growth hormone in schizophrenics as compared to control subjects","volume":"88","author":"Gil-Ad","year":"1986","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.psyneuen.2004.11.003_bib18","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1176\/ajp.150.4.653","article-title":"Association of nonsuppression on the DST with primary polydipsia in chronic schizophrenia","volume":"150","author":"Goldman","year":"1993","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2004.11.003_bib19","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1001\/archpsyc.1997.01830170069010","article-title":"Psychotic exacerbations and enhanced vasopressin secretion in schizophrenic patients with hyponatremia and polydipsia","volume":"54","author":"Goldman","year":"1997","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psyneuen.2004.11.003_bib20","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1210\/endo.136.3.7867583","article-title":"Vasopressin stimulates steroid hormone secretion in human adrenal glands: comparison with angiotensin-II effect","volume":"136","author":"Guillon","year":"1995","journal-title":"Endocrinology"},{"key":"10.1016\/j.psyneuen.2004.11.003_bib21","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1210\/jcem-54-6-1262","article-title":"The mean 1300-1600 h plasma cortisol concentration as a diagnostic test for hypercortisolaemia","volume":"54","author":"Halbreich","year":"1982","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.psyneuen.2004.11.003_bib22","series-title":"Clinical Endocrinology","first-page":"1096","article-title":"The endocrinology of mental disease","author":"Holsboer","year":"1998"},{"key":"10.1016\/j.psyneuen.2004.11.003_bib23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3109\/15622970109039981","article-title":"Neuroendocrine effects of a short-term osmotic stimulus in patients with chronic schizophrenia","volume":"2","author":"Hundt","year":"2001","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2004.11.003_bib24","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s002130000381","article-title":"Selective impairments in the stress response in schizophrenic patients","volume":"149","author":"Jansen","year":"2000","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.psyneuen.2004.11.003_bib25","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0278-5846(02)00208-7","article-title":"The hypothalamic-pituitary\u2013adrenal axis in chronic schizophrenic patients long-term treated with neuroleptics","volume":"26","author":"Kaneda","year":"2002","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2004.11.003_bib26","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1210\/jcem-47-1-204","article-title":"Lack of arginine vasopressin response to central dopamine blockade in normal adults","volume":"47","author":"Kendler","year":"1978","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.psyneuen.2004.11.003_bib27","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1176\/ajp.144.1.82","article-title":"Psychotropic drug withdrawal and the dexamethasone suppression test","volume":"144","author":"Kraus","year":"1987","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2004.11.003_bib28","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000026498","article-title":"Increased plasma vasopressin and atrial naturetic peptide in chronic schizophrenic patients during abdominal surgery","volume":"37","author":"Kudoh","year":"1998","journal-title":"Neurospcyhobiology"},{"key":"10.1016\/j.psyneuen.2004.11.003_bib29","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/0306-4530(92)90019-4","article-title":"Apomorphine stimulation of vasopressin and oxytocin-neurophysins. Evidence for increased oxytocinergic and decreased vasopressinergic function in schizophrenia","volume":"17","author":"Legros","year":"1992","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2004.11.003_bib30","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/BF00461555","article-title":"Cerebrospinal fluid neurophysins in affective illness and in schizophrenia","volume":"234","author":"Linkowski","year":"1984","journal-title":"Eur. Arch. Psychiatry Neurol. Sci."},{"key":"10.1016\/j.psyneuen.2004.11.003_bib31","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1046\/j.1471-4159.2003.01635.x","article-title":"Dopamine-dependent responses to cocaine depend on corticotropin-releasing factor receptor subtypes","volume":"84","author":"Lu","year":"2003","journal-title":"Neurochemistry"},{"key":"10.1016\/j.psyneuen.2004.11.003_bib32","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0006-3223(96)00491-X","article-title":"Anterior medial temporal volumes in polydipsic schziophrenic patients with and without hypo-osmolelia: a pilot study","volume":"42","author":"Luchins","year":"1997","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2004.11.003_bib33","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1365-2265.1984.tb03450.x","article-title":"The effects of metoclopramide on plasma vasopressin in man","volume":"21","author":"Nomura","year":"1984","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.psyneuen.2004.11.003_bib34","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1210\/jcem-63-3-747","article-title":"Metoclopramide increases vasopressin secretion","volume":"63","author":"Norbiato","year":"1986","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.psyneuen.2004.11.003_bib35","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1046\/j.1365-2826.1999.00405.x","article-title":"Long-term treatment with antidepressants increases glucocorticoid receptor binding and gene expression in cultured rat hippocampal neurones","volume":"11","author":"Okugawa","year":"1999","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.psyneuen.2004.11.003_bib36","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The brief psychiatric rating scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychol. Rep."},{"key":"10.1016\/j.psyneuen.2004.11.003_bib37","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/sj.bjp.0704368","article-title":"Antidepressants enhance glucocorticoid receptor function in vitro by modulating the membrane steroid transporters","volume":"134","author":"Pariante","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.psyneuen.2004.11.003_bib38","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1210\/endo.139.7.6121","article-title":"Glucocorticoids increase vasopressin V1b receptor coupling to phospholipase C","volume":"139","author":"Rabadan-Diehl","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.psyneuen.2004.11.003_bib39","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0165-1781(95)02525-2","article-title":"Circadian rhythm of vital signs, norepinephrine, epinephrine, thyroid hormones and cortisol in schizophrenia","volume":"57","author":"Rao","year":"1995","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psyneuen.2004.11.003_bib40","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0033-3182(91)72084-7","article-title":"A review of disorders of water homeostasis in psychiatric patients","volume":"32","author":"Riggs","year":"1991","journal-title":"Psychosomatics"},{"key":"10.1016\/j.psyneuen.2004.11.003_bib41","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/15321818208056990","article-title":"A new sensitive radioimmunoassay for plasma arginine vasopressin","volume":"3","author":"Rooke","year":"1982","journal-title":"J. Immunoassay"},{"key":"10.1016\/j.psyneuen.2004.11.003_bib42","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1176\/ajp.143.11.1393","article-title":"The corticotropin-releasing hormone stimulation test in chronic schizophrenia","volume":"143","author":"Roy","year":"1986","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2004.11.003_bib44","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0024-3205(02)01646-6","article-title":"Physical consequences of schizophrenia","volume":"71","author":"Ryan","year":"2002","journal-title":"Life Sci."},{"key":"10.1016\/j.psyneuen.2004.11.003_bib43","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.psyneuen.2003.08.011","article-title":"Evidence of basal pituitary\u2013adrenal overactivity in first episode, drug na\u00efve patients with schizophrenia","volume":"29","author":"Ryan","year":"2004","journal-title":"Pyschoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2004.11.003_bib45","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.1365-2265.1997.t01-22-1150928.x","article-title":"Corticotrophin and vasopressin responses to metoclopramide in patients with hypothalamic amenorrhoea","volume":"46","author":"Seki","year":"1997","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.psyneuen.2004.11.003_bib46","unstructured":"Statistical Graphics Corporation, 1993. Statgraphics, Version 7.0, New York."},{"key":"10.1016\/j.psyneuen.2004.11.003_bib47","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1001\/archpsyc.1991.01810280064009","article-title":"Circadian and sleep-related endocrine rhythms in schizophrenia","volume":"48","author":"Van Cauter","year":"1991","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psyneuen.2004.11.003_bib48","series-title":"Biological Psychiatry","first-page":"339","article-title":"Spinal fluid","author":"Van Kammen","year":"1981"},{"key":"10.1016\/j.psyneuen.2004.11.003_bib49","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1210\/jcem-71-6-1616","article-title":"Twenty four hour rhythmns in plasma concentration of adenohypophyseal hormones are generated by distinct amplitude and\/or frequency modulation of underlying pituitary secretory bursts","volume":"71","author":"Veldhuis","year":"1990","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.psyneuen.2004.11.003_bib50","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1210\/jcem-33-1-14","article-title":"Twenty four hour patterns of the episodic secretion of cortisol in normal subjects","volume":"33","author":"Weitzman","year":"1971","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.psyneuen.2004.11.003_bib51","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1192\/bjp.155.4.455","article-title":"Disturbed endocrine function in the psychoses I: Disordered homeostasis or disease process?","volume":"155","author":"Whalley","year":"1989","journal-title":"Br. J. Psychiatry"}],"container-title":["Psychoneuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453004001805?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453004001805?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T16:26:34Z","timestamp":1759681594000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306453004001805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["S0306453004001805"],"URL":"https:\/\/doi.org\/10.1016\/j.psyneuen.2004.11.003","relation":{},"ISSN":["0306-4530"],"issn-type":[{"value":"0306-4530","type":"print"}],"subject":[],"published":{"date-parts":[[2005,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Male patients with paranoid schizophrenia have greater ACTH and cortisol secretion in response to metoclopramide-induced AVP release","name":"articletitle","label":"Article Title"},{"value":"Psychoneuroendocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psyneuen.2004.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}